





<!DOCTYPE html>
<html lang="en" dir="ltr" prefix="og: https://ogp.me/ns#">
  


<head>
      <script type="text/javascript">
    var otsuka_dl = { 
    "page": {
        "business_function": "commercial", 
        "therapeutic_area": "nephrology", 
        "business_affiliate": "oapi", 
        "site_language": "english", 
        "brand_name": "jynarque", 
        "side_of_brand": "hcp", 
        "indication": "autosomal dominant polycystic kidney disease (adpkd)", 
        "root_domain": "jynarquehcp.com"
    } 
};
  </script>

        <title>About ADPKD | HCP JYNARQUE速 (tolvaptan) tablets</title>
    <meta charset="utf-8" />
<meta name="description" content="Learn about Autosomal Dominant Polycystic Kidney Disease (ADPKD) including symptoms &amp; diagnosis. See FULL PRESCRIBING INFORMATION, including BOXED WARNING." />
<meta name="keywords" content="ADPKD, autosomal dominant polycystic kidney disease, tolvaptan, JYNARQUE" />
<link rel="canonical" href="about.html" />
<meta name="google-site-verification" content="S979W9LEDXsQQvi7sUkEAwBRLEs0M_9EhYns57YIycs" />
<meta name="Generator" content="Drupal 10 (https://www.drupal.org)" />
<meta name="MobileOptimized" content="width" />
<meta name="HandheldFriendly" content="true" />
<meta name="viewport" content="width=device-width, initial-scale=1.0" />
<script src="https://cdn.cookielaw.org/scripttemplates/otSDKStub.js" type="text/javascript" charset="UTF-8" data-domain-script="0190fcfe-c0de-7b85-b039-75fd69273f8a" defer="defer"></script>
<script type="text/javascript" defer="defer">
  function waitForElm(selector) {
    return new Promise(function (resolve) {
      if (document.querySelector(selector)) {
        return resolve(document.querySelector(selector));
      }
      const observer = new MutationObserver(function (mutations) {
        if (document.querySelector(selector)) {
          observer.disconnect();
          resolve(document.querySelector(selector));
        }
      });
      observer.observe(document.body, {
        childList: true,
        subtree: true
      });
    });
  }
  function oneTrustAddFont() {
    const link = document.createElement('link');
    link.rel = 'stylesheet';
    link.type = 'text/css';
    link.href = 'https://fonts.googleapis.com/css?family=Montserrat';
    document.getElementsByTagName('HEAD')[0].appendChild(link);
  }
  function addMeta() {
    const meta = document.createElement('meta');
    meta.name = 'viewport';
    meta.content = 'width=device-width, initial-scale=1.0';
    document.getElementsByTagName('head')[0].appendChild(meta);
  }
  function oneTrustBannerFooterFix() {
    const divSelector = document.querySelector('#onetrust-button-group-parent');
    const elementDiv = document.createElement('div');
    elementDiv.className = 'ontrust_logo';
    elementDiv.innerHTML = "<div class='green-logo'> onetrust</div><div class='text-logo'>Powered by</div>";
    divSelector.parentNode.insertBefore(elementDiv, divSelector.nextSibling);
    document.getElementsByClassName('ot-pc-footer-logo')[0].children[0].removeAttribute('href');
  }
  function oneTrustBannerOtherFix() {
    var p = document.querySelectorAll('.ot-accordion-layout p');
    Array.prototype.forEach.call(p, function(el) {
      el.innerHTML = el.innerHTML.replace(/&nbsp;/gi, '');
    });
    let tabindex = 2;
    document.querySelectorAll('#onetrust-button-group button, #onetrust-button-group input').forEach(function (element) {
      element.setAttribute('tabindex', String(tabindex));
      if (tabindex === 2) {
        tabindex = 1;
      } else if (tabindex === 1) {
        tabindex = 3;
      } else {
        tabindex++;
      }
    });
    document.querySelector('#onetrust-policy-text a').setAttribute('tabindex', 1);
  }
  function oneTrustSettingsButtonFix() {
    const acceptBtn = document.getElementById('accept-recommended-btn-handler');
    const rejectBtn = document.getElementsByClassName('ot-pc-refuse-all-handler')[0];
    const container = document.getElementsByClassName('ot-btn-container')[0];
    container.prepend(acceptBtn, rejectBtn);
  }
  function oneTrustSettingsOtherFix() {
    const modelElement = document.getElementById('onetrust-pc-sdk');
    document.addEventListener('focus', function (e) {
      const focusableElements = modelElement.querySelectorAll('a[href], area[href], input:not([disabled]), select:not([disabled]), textarea:not([disabled]), button:not([disabled]), iframe, object, embed, *[tabindex], *[contenteditable]');
      if (!Array.from(focusableElements).includes(e.target)) {
        Array.from(focusableElements)[0].focus();
      }
    }, true);
  }
  oneTrustAddFont();
  addMeta();
  document.addEventListener('DOMContentLoaded', function () {
    waitForElm('#onetrust-banner-sdk').then(function () {
      oneTrustBannerFooterFix();
      oneTrustBannerOtherFix();
    });
    waitForElm('#onetrust-pc-sdk').then(function () {
      oneTrustSettingsButtonFix();
      oneTrustSettingsOtherFix();
    });
  });
</script>
<script></script>
<link rel="preconnect" href="https://fonts.googleapis.com/" />
<link rel="preconnect" href="https://fonts.gstatic.com/" crossorigin="anonymous" />
<link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Source+Sans+Pro:ital,wght@0,300;0,400;0,600;0,700;0,900;1,300;1,400;1,700&amp;display=swap" type="text/css" />
<script src="https://assets.adobedtm.com/3f0d2e2dbd42/313fd7baa8af/launch-bacdce8b01b7.min.js" type="text/javascript" async></script>
<meta name="format-detection" content="telephone=no" />
<link rel="icon" href="../sites/g/files/qhldwo11641/files/favicon.ico" type="image/vnd.microsoft.icon" />
<script type="application/ld+json">{
    "@context": "https://schema.org",
    "@type": "MedicalWebPage",
    "audience": "Clinician",
    "specialty": "Renal",
    "url": "https://www.jynarquehcp.com/adpkd/about",
    "headline": [
        "ADPKD is a genetic, progressive disease",
        "SIGNS AND SYMPTOMS OF ADPKD CAN BE DIFFICULT TO IDENTIFY",
        "OTHER FACTORS TO CONSIDER WHEN DIAGNOSING ADPKD",
        "DIAGNOSING ADPKD"
    ],
    "abstract": "AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) IS CHARACTERIZED BY THE CONTINUOUS DEVELOPMENT AND ENLARGEMENT OF CYSTS IN THE KIDNEYS",
    "description": [
        "Ultrasound is the most commonly used imaging modality for a diagnosis of ADPKD",
        "Unified ultrasonographic criteria for diagnosis of ADPKD in patients with positive family history (Pei criteria)*14,15*: 15-39 years At least 3 renal cysts, 40-59 years At least 2 cysts in each kidney, Over 60 years At least 4 cysts in each kidney.",
        "When there is no clear family history: Genetic testing is available to help confirm a diagnosis, Multiple factors should be considered, including the age of the patient, presence of associated manifestations (ie, liver cysts), bilaterally enlarged kidneys, and &gt;10 cysts in each kidney16"
    ],
    "name": "About ADPKD",
    "breadcrumb": {
        "@type": "BreadcrumbList",
        "itemListElement": [
            {
                "@type": "ListItem",
                "position": 1,
                "item": {
                    "@id": "https://www.jynarquehcp.com/",
                    "name": "Homepage"
                }
            },
            {
                "@type": "ListItem",
                "position": 2,
                "item": {
                    "@id": "https://www.jynarquehcp.com/adpkd/about",
                    "name": "About ADPKD"
                }
            }
        ]
    },
    "mainContentOfPage": {
        "@type": "WebPageElement",
        "potentialAction": [
            {
                "@type": "Action",
                "name": "Review Patient Identification",
                "description": "Learn how to identify adult patients at risk of rapidly progressing ADPKD",
                "url": "https://www.jynarquehcp.com/patient-identification"
            },
            {
                "@type": "Action",
                "name": "Learn more",
                "description": "Discover how kidney size can be a helpful measure in assessing your patients for disease progression",
                "url": "https://www.jynarquehcp.com/adpkd/progression"
            }
        ]
    },
    "video": [
        {
            "@type": "VideoObject",
            "name": "HEAR ABOUT DISEASE PROGRESSION",
            "description": "Hear about disease progression",
            "thumbnailUrl": [
                "https://i.vimeocdn.com/video/1752761447-dcb34ab7bbcd838d891ab36f4d8949aa1dc31c08b3d7a11798f38def4fa40cd9-d_640?f=webp"
            ],
            "uploadDate": "2023-11-13T03:52:30-05:00",
            "duration": "PT70S",
            "contentUrl": "https://www.jynarquehcp.com/adpkd/about",
            "embedUrl": "https://player.vimeo.com/video/883903563"
        }
    ],
    "about": [
        {
            "@type": "MedicalCondition",
            "name": "Autosomal Dominant Polycystic Kidney Disease",
            "alternateName": [
                "ADPKD",
                "Autosomal Dominant Polycystic Kidney Disease (ADPKD)"
            ],
            "description": [
                "Over time, enlarging cysts can increase kidney size by up to 4 times that of normal kidneys5",
                "Enlarging cysts contribute to the compression and loss of surrounding functional renal tissue, resulting in a progressive decline of renal function",
                "The damage caused by enlarging cysts and the increase in kidney size become irreversible, which eventually leads to end-stage kidney disease (ESKD)6",
                "ADPKD is a heterogeneous renal disease with a high degree of symptom variability",
                "Hepatic cysts are the most common extra-renal manifestation in patients with ADPKD3",
                "Multiple techniques can be used to confirm a diagnosis of ADPKD12",
                "Diagnosis of ADPKD is typically established on the basis of: Positive family history &amp; imaging studies."
            ],
            "riskFactor": [
                "A parent with ADPKD has a 50% chance of passing the disease on to each of their children.",
                "Although ADPKD is a genetic disease, family history may be unknown. When patients experience symptoms related to ADPKD, the disease may not be promptly recognized. As a result, years can elapse before the diagnosis of ADPKD is made."
            ],
            "epidemiology": [
                "Even though ADPKD impacts all races, research shows that patient outcomes, such as early diagnosis and treatment of ADPKD, may vary by race and ethnicity attributed to social determinants of health (SDOH).",
                "Though more extensive research is needed, based on the available data, it's important to consider the following: Other conditions that are more common in Black patients with ADPKD, such as hypertension, diabetes, or sickle cell, have the potential to mask an ADPKD diagnosis11"
            ],
            "signOrSymptom": [
                "Renal Manifestations",
                "Hypertension",
                "Nocturia",
                "Polyuria, Hematuria",
                "Palpable kidneys",
                "Kidney stones",
                "Abdominal/flank pain",
                "Recurrent UTIs",
                "Extra-Renal Manifestations",
                "Intracranial aneurysms",
                "Vascular dissections",
                "Valvular heart disease",
                "Hepatic cysts",
                "Diverticulosis",
                "Abdominal wall hernias."
            ]
        },
        {
            "@type": "MedicalTherapy",
            "guideline": [
                "Strong CYP3A Inducers: Co-administration with strong CYP3A inducers reduces exposure to JYNARQUE. Avoid concomitant use of JYNARQUE with strong CYP3A inducers",
                "V2-Receptor Agonist: Tolvaptan interferes with the V2-agonist activity of desmopressin (dDAVP). Avoid concomitant use of JYNARQUE with a V2-agonist"
            ],
            "adverseOutcome": [
                "Most common observed adverse reactions with JYNARQUE (incidence &gt;10% and at least twice that for placebo) were thirst, polyuria, nocturia, pollakiuria and polydipsia."
            ],
            "seriousAdverseOutcome": [
                "Serious Liver Injury: JYNARQUE can cause serious and potentially fatal liver injury. Acute liver failure requiring liver transplantation has been reported in the post-marketing ADPKD experience. Discontinuation in response to laboratory abnormalities or signs or symptoms of liver injury (such as fatigue, anorexia, nausea, right upper abdominal discomfort, vomiting, fever, rash, pruritus, icterus, dark urine or jaundice) can reduce the risk of severe hepatotoxicity. To reduce the risk of significant or irreversible liver injury, assess ALT, AST and bilirubin prior to initiating JYNARQUE, at 2 weeks and 4 weeks after initiation, then monthly for 18 months and every 3 months thereafter.",
                "Hypernatremia, Dehydration and Hypovolemia: JYNARQUE therapy increases free water clearance which can lead to dehydration, hypovolemia and hypernatremia. Instruct patients to drink water when thirsty, and throughout the day and night if awake. Monitor for weight loss, tachycardia and hypotension because they may signal dehydration. Ensure abnormalities in sodium concentrations are corrected before initiating therapy. If serum sodium increases above normal or the patient becomes hypovolemic or dehydrated and fluid intake cannot be increased, suspend JYNARQUE until serum sodium, hydration status and volume status parameters are within the normal range.",
                "Inhibitors of CYP3A: Concomitant use of JYNARQUE with drugs that are moderate or strong CYP3A inhibitors (e.g., ketoconazole, itraconazole, lopinavir/ritonavir, indinavir/ritonavir, ritonavir, and conivaptan) increases tolvaptan exposure. Use with strong CYP3A inhibitors is contraindicated; dose reduction of JYNARQUE is recommended for patients taking moderate CYP3A inhibitors. Patients should avoid grapefruit juice beverages while taking JYNARQUE."
            ],
            "contraindication": [
                "History, signs or symptoms of significant liver impairment or injury. This contraindication does not apply to uncomplicated polycystic liver disease",
                "Taking strong CYP3A inhibitors",
                "With uncorrected abnormal blood sodium concentrations",
                "Unable to sense or respond to thirst",
                "Hypovolemia",
                "Hypersensitivity (e.g., anaphylaxis, rash) to JYNARQUE or any component of the product",
                "Uncorrected urinary outflow obstruction",
                "Anuria"
            ],
            "recognizingAuthority": {
                "@type": "Organization",
                "name": "U.S. Food and Drug Administration",
                "alternateName": "FDA",
                "url": "https://www.fda.gov/"
            }
        },
        {
            "@type": "Drug",
            "Name": "JYNARQUE速",
            "nonProprietaryName": "tolvaptan",
            "activeIngredient": "tolvaptan",
            "alternateName": "JYNARQUE (tolvaptan)",
            "dosageForm": "tablets",
            "administrationRoute": "oral",
            "doseSchedule": [
                {
                    "@type": "DoseSchedule",
                    "frequency": "Daily",
                    "doseUnit": "mg",
                    "doseValue": [
                        "60",
                        "90",
                        "120"
                    ],
                    "targetPopulation": "adults at risk of rapidly progressing autosomal dominant polycystic kidney disease (ADPKD)."
                }
            ],
            "offers": {
                "@type": "Offer",
                "description": "Eligible patients pay as little as $10 per month for JYNARQUE*",
                "price": "10",
                "priceCurrency": "USD",
                "url": "https://www.jynarquerems.com/"
            },
            "pregnancyWarning": "Based on animal data, JYNARQUE may cause fetal harm. In general, JYNARQUE should be discontinued during pregnancy.",
            "breastfeedingWarning": "Advise women not to breastfeed during treatment with JYNARQUE.",
            "warning": [
                "JYNARQUE速 (tolvaptan) can cause serious and potentially fatal liver injury. Acute liver failure requiring liver transplantation has been reported",
                "Measure transaminases (ALT, AST) and bilirubin before initiating treatment, at 2 weeks and 4 weeks after initiation, then monthly for the first 18 months and every 3 months thereafter. Prompt action in response to laboratory abnormalities, signs, or symptoms indicative of hepatic injury can mitigate, but not eliminate, the risk of serious hepatotoxicity",
                "Because of the risks of serious liver injury, JYNARQUE is available only through a Risk Evaluation and Mitigation Strategy program called the JYNARQUE REMS Program"
            ],
            "image": "https://www.jynarquehcp.com/sites/g/files/qhldwo8636/themes/site/themes/custom/jynarque_hcp/assets/build/img/jynarque-logo.png",
            "manufacturer": {
                "@type": "Organization",
                "name": "Otsuka America Pharmaceutical, Inc.",
                "logo": "https://www.jynarquehcp.com/sites/g/files/qhldwo8636/files/inline-images/otsuka_logo2.png"
            }
        }
    ]
}</script>

        <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <link rel="stylesheet" media="all" href="../sites/g/files/qhldwo11641/files/css/optimized/css_97htjIvQ15V1EfeTASftshiMIzLS36LIXVDogWwnlWQ.IJ5KA0xBsRRaiRPaWB6Sh9PN3WKo_EsNIYaw8SqYqYc1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="../sites/g/files/qhldwo11641/files/css/optimized/css_Zru9LBZ0sAXcjonUFHSutTAZkU-sNKpHr1JGBQ4FyU0.bkPvoFYCA2Lixa4KISvTdT3EKjCHiKrtKcE261byVx01cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="../sites/g/files/qhldwo11641/files/css/optimized/css_kzULKG5pzGyNLykluQb5oDJTQPcLlJKzZ5imyM6J1h8.b9DwpaiAlb0lsM657D5Lniy-cPNAkk4Cxr45yy473q41cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="../sites/g/files/qhldwo11641/files/css/optimized/css_uI2FntcPi0s7LE7aVRLFPdaOjEJ2AvgJxZxn7U_KEpU.uS1FFwOJYeXSeF3bIVSvkMkrHh5opqqW_F79rAx63B01cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="../sites/g/files/qhldwo11641/files/css/optimized/css_LyrrR6JZO8eTCViUPzg899V1r3IBqMYsy9zQoA-d_xo.Awf46AhlxtFml2KQ8H4-E0dZzxzlJb1Ua0P5_ptOC4k1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="../sites/g/files/qhldwo11641/files/css/optimized/css_YuXFCqJ6Mh9c2Lz522vxxQKwCuYdi4B4eglcgrxGnjc.xk_yrolxl9EFVCS6-YD3__eEEiB4lkwtBVMLZeTfMbA1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="../sites/g/files/qhldwo11641/files/css/optimized/css_Awu9YtmWu_taaaaJKswYqKQEUWlATiU0b-9Ka6etFfU.pYA92qiAPS662AtCQt6lMeZYgkI683UmfkdP-4BIymA1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="../sites/g/files/qhldwo11641/files/css/optimized/css_yIJuzHvo1e460jlmqttlj52OMZk0ZV7QmKCy-1vP5ZI.qAT_vNKdppWlPfwRvdNPIJfErkIfxMw2j_eesucANOI1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="../sites/g/files/qhldwo11641/files/css/optimized/css_xnDYBl4OD9snX7Sf9EyJ9VkzRg71lff1OegyGLU8z1w.l_5ZkiCBh5EcPa_3_oVW7iVMoKNAq5rw47oEzn5A4uM1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="../sites/g/files/qhldwo11641/files/css/optimized/css_gfUtLDXi72df47AexuJ-vm_wJb2QkME0vEvBnJxO6dA.x5nsh_uKblK9k6iDq9xx7vDex30jZc5ML0YXij4JCf01cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="../sites/g/files/qhldwo11641/files/css/optimized/css_CYXnyo1qFoxHAoBBNsSqN8PVNbP8sxeQ_LtauZ50Wgs.g1uXGwNn2HpE6NbJGbnMjYWIh7kyfoVz_UhSlBh2o3s1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="../sites/g/files/qhldwo11641/files/css/optimized/css_QF7anExUIQ9m7lRlQYpqk7QebuejK_k7Tyzw3UgZ-hg.PZJw_IXbQZH7i6WEC-FHNDBoI3_PTyzLEmC7wWy4oTU1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="../sites/g/files/qhldwo11641/files/css/optimized/css_7QllbjqoprdCwoIdo3V7DWqJKkTBOzMJn-xZmsutiww.8xdGy7dXc6zJNYRxgF4k0vgBhKloby5N-_V1MMOlg8A1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="../sites/g/files/qhldwo11641/files/css/optimized/css_hnJTGN1fzih_ZZssV428NML2NhpFxXlJrqaLNgE8CHo.F9pmb7LygmrpoeT1fXJA7PaAVf2oWybBXF5F5Eihki41cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="../sites/g/files/qhldwo11641/files/css/optimized/css__13fw7LchbE-h7zw4b3GPIwiFWcaKaefv7L39uOe9so.KNMtBlCBCom77JyoWGB48Q3ueDS7rzZa_7XYX8jrDaA1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="../sites/g/files/qhldwo11641/files/css/optimized/css_0jPT-BWLonFoD1a1XPcxcniBn9WgukRnniaE-xYrMIs.eYuzxX6GcmG8wPZRhL7aCvvGdgilCJbuAMMEoRSvz4o1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="../sites/g/files/qhldwo11641/files/css/optimized/css_wcTRp4Ty5SGu4F6Mj_Src4xCVH1pAn1ZKdFhbgibbUI.Sk-ip5PYfIjxUJ83DbxAtt7sIYi2qRj5I2X4c7e8Vm01cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="../sites/g/files/qhldwo11641/files/css/optimized/css_XYJeCymlgeYq2fA8gUC7CjnYFGGkur-vgRftab7u22k.kpMc62oK0cmz6PxvM1ud_W8MfI7jbwibsQJBwUKnj6o1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="../sites/g/files/qhldwo11641/files/css/optimized/css_GbvmbJJu3etNuvRxzgpArn9FbrGIPob5sKfVZm03KVw.b0Zuw7zuYwqRxAI1V79cTc_023d639V2bQ6KyuEtbY01cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="../sites/g/files/qhldwo11641/files/css/optimized/css_Q6hS9heFRWwmGWvo9WsD_D6nDHdUaUnYt6sC6_oX9L8.KZBkzzAnxe-rSrbfNF3hMC36Vi24PspRllNxk4SA9Ww1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="../sites/g/files/qhldwo11641/files/css/optimized/css_41w6dBZ448pJSogyLgoToui9MDm8KnZHhhxIUFUonds.PQ-2T_xzJKQYbbkpGgIM9A4s115DO680EaZM47Z16XI1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="../sites/g/files/qhldwo11641/files/css/optimized/css_JCU_zSqQm3rvBIXWevl-Uch6AS6Fms27h_AxAbdSM2A.2mNgp1qsab5wdrSlpKLQv707xKZ0u6LnqctpgDVxkVk1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="../sites/g/files/qhldwo11641/files/css/optimized/css__7a65Qsn2GbI6R4HiSGaSbf2n93vUm8S71hKr7aus8Y.0Qb5zpcCHmzpoF5ZOnDsfklWZn6rg3JsnrG0c7cJ-441cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="../sites/g/files/qhldwo11641/files/css/optimized/css_PRpLCpZQr4zTfafBQvuU6Ai1fdWr3UHToA3uiawHjkM.fLPfLB0XwmNrMgpuaRfK4T-BBNy7nDIXycFgFzdHoEQ1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="../sites/g/files/qhldwo11641/files/css/optimized/css_2fOIiKYvhnv1KtlkfBN2k0dROF50_VqtX1AygAXbRUU.a_ZLSp52H6ZconNljM9h1TZl4ovw7N0npH7nKInNWJg1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="../sites/g/files/qhldwo11641/files/css/optimized/css_Z-5TKx9kThxW5rYM3vQRCBc8GEdIN_NvKS9iqhDQafw.RyxC-gT9frmBMijOhY3C3K32AabFm7-q9HkDsnP6XHU1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="../sites/g/files/qhldwo11641/files/css/optimized/css_Q7zLgQvyD3dkOHXnT2wFwjtThfQupYWs-a29sqLPi4I.NBaa9xsCtF_rCNvid3JjjAs77Sb-JtnwFbAZvmTkOJs1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="../sites/g/files/qhldwo11641/files/css/optimized/css_B_2jVuT6jLLyb7aSeSEqk36PnVz0mEI5zK7uqVBaJLw.smsRBGGy-MttVliRuPwj_TEI4mBHLeiSE32C0BkTq6M1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="../sites/g/files/qhldwo11641/files/css/optimized/css_kJqax_RkZBAk2I3Nq_rTD9LHc0oMwWKlanYK42ORIfM.zTSiciBJCN04ULznc2T1MWG59Py-6ONyTHVVm-YCHX41cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="../sites/g/files/qhldwo11641/files/css/optimized/css_vOD9-5JiqhFy7oiIOzO00o2XLgmR6XH8SUL8LL585Vc.8e6pTB1_nGdHUV4devYGGEmOgZeQXykLw4UdpB-9VYg1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="../sites/g/files/qhldwo11641/files/css/optimized/css_syNh2ZBM2xlmOdBPf0FR8w7O-hHQEBa956Kp_ldOSBg.xkGZo2gAdcfeCasz9E7IXM7UlmN8zg2sNe-DUmghXI01cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="../sites/g/files/qhldwo11641/files/css/optimized/css_q2E2y5MBPRf422vpPN0DME5tgpDakJKU8shGsBJGndg.qvqk-z17E7JlX9pYx8b0C1UIaYryHrpXqqt4Sdflos01cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="../sites/g/files/qhldwo11641/files/css/optimized/css_kPUtqisf0lrHdJsPV-HJ8wEHOFRbSDxP-pzEt2drCg8.j317pwJpjGUayMMKAkpZNtp2AGp5H841Sotc8GzQsmA1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="../sites/g/files/qhldwo11641/files/css/optimized/css_72hPqoJe-nQn5JSLcTSsq-8EzuUCzbBorORCeiy63lY.BQL5zBoJQoPqzp_mWq9aUMUOA6_UPJ_lEeMTz5PSoDo1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="../sites/g/files/qhldwo11641/files/css/optimized/css_3-74lGc_qnWeX8UeqKX-LZDQJky2QvbaHFfo4iNTZ6k.POmC--YL2K5Oj8dGp36jOmTLjLa3WnQ1Klk-RmN5cKg1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="../sites/g/files/qhldwo11641/files/css/optimized/css_Rz4CyfU-tt37njBy44WX-XrS4zxnMhF_6Go4o7UwLGI.79bAlAvX0LU9yDuY5LxmPLL7t8w3aVVw1vo8avMA8kA1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="../sites/g/files/qhldwo11641/files/css/optimized/css_2q3_cDI6RdqHnRwH_XgoPOAwo9FXO-tcqG_yT6CPe9s.l458SJWUrwPoMnJnZ_5qDN0jqPz6K5dCJoQ9UXnA_DI1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="../sites/g/files/qhldwo11641/files/css/optimized/css_0HuNciDfYnF1bgCrWDJ7vWP6DBbES-2NaoX7LS-7J7w.sGFI40X4eJmPcLu8FKNKbJRZE9vl-RCYCItbleoETAc1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="../sites/g/files/qhldwo11641/files/css/optimized/css_Lln5SjQMuv2n0S-BExbI8cautmTrPcQVykeaA52uFro.s9dBNdMMOtzUsW-YvDIx7BASbgV1sw0AIYdtS9bmP9k1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="../sites/g/files/qhldwo11641/files/css/optimized/css_MCt3mn2BRlH9NZKS7MdM7wWfnp-dm2AkU4KVMbt3EyQ.L2SSSnCwWtoQBxhUKpTXhmLYmn6R6PZ-KU4ouXzLIVc1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="../sites/g/files/qhldwo11641/files/css/optimized/css_GmyqFQFQe25qXoOyEGVD699zKQpLw_GqHA7ZPIgbbw4.7ZO1nmmOSbqX0BcPwxfG0l3f23_Kbss-E02-PzWTtN41cee.css?t5xpr9" />

    <script type="application/json" data-drupal-selector="drupal-settings-json">{"path":{"baseUrl":"\/","pathPrefix":"","currentPath":"node\/25846","currentPathIsAdmin":false,"isFront":false,"currentLanguage":"en","themeUrl":"sites\/g\/files\/qhldwo11641\/themes\/site\/themes\/custom\/jynarque_hcp"},"pluralDelimiter":"\u0003","gtag":{"tagId":"","consentMode":false,"otherIds":[],"events":[],"additionalConfigInfo":[]},"suppressDeprecationErrors":true,"ajaxPageState":{"libraries":"eJx1j1mSwyAMRC_kmCOp2qDBJAIxLEl8-3GWKduz_FBSq-l6DacTk6AnOxvslsGremFq8Mavz899xBn3oxiH85JQPjvTbLOxvTaNpwzPI1y-uBMm7e1o8qIT5FTbIiH54y2p49FChJoSbAuajoaMAl-Q5zpaFUGuYVppCn9w4WS5_mtPfG_0IKNH_i-qa-Dbmvks8LK10IQHbbVfQFuQmVA3uYQr7EJWY5aA1CiyCzDfZxsJOQy73670DBl3YD3lPkmoM7shzygRFGow2_i3Sq7gxmWoS20cX1TPEu8qUV0X_gJ_UsI8","theme":"jynarque_hcp","theme_token":null},"ajaxTrustedUrl":[],"gtm":{"tagId":null,"settings":{"data_layer":"dataLayer","include_classes":false,"allowlist_classes":"google\nnonGooglePixels\nnonGoogleScripts\nnonGoogleIframes","blocklist_classes":"customScripts\ncustomPixels","include_environment":false,"environment_id":"","environment_token":""},"tagIds":["GTM-W8LVZL2"]},"privacy_compliant_media_settings":{"enabled":1,"general":{"error_cmp_not_found":"Consent management is currently disabled, website functionality may be affected. Please try reloading the page."},"youtube":{"enabled":0,"cat_id":"C0002","dependent_cat_id":"C0004","modal":{"description":"To start your video we need your permission to use YouTube cookies. These cookies help us make other video recommendations specific to your interests.","consent_label":"Allow YouTube cookies","morelink_label":"Learn more about cookies","morelink_url":"javascript:OneTrust.ToggleInfoDisplay();"},"overlay_image":null},"vimeo":{"enabled":1,"cat_id":"C0008","dependent_cat_id":"C0004","modal":{"description":"By clicking \u0027Accept\u0027, you will enable functional cookies that are necessary for the video\u0027s playback on this platform. These cookies can be reviewed \u003Ca  href=\u0022javascript:OneTrust.ToggleInfoDisplay();\u0022\u003Ehere\u003C\/a\u003E and adjusted at any time by clicking the shield above. Want to know more? View our \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/www.otsuka-us.com\/privacy-policy\u0022\u003EPrivacy Notice\u003C\/a\u003E.\r\n\u003Ca class=\u0022otsuka-pcm-consent-link\u0022 href=\u0022javascript:OneTrust.ToggleInfoDisplay();\u0022 role=\u0022button\u0022 aria-label=\u0022Privacy Notice\u0022\u003EPrivacy Notice\u003C\/a\u003E","consent_label":"Accept","morelink_label":"","morelink_url":""},"overlay_image":null},"buzzsprout_podcasts":{"enabled":0,"cat_id":"C0002","modal":{"description":"To start your podcast we need your permission to contact Buzzsprout. This allows us to place a podcast player widget on the page.","consent_label":"Allow Buzzsprout player","morelink_label":"","morelink_url":""},"overlay_image":null},"orbita_live_chat":{"enabled":0,"cat_id":"C0002","widget":{"wrapper_id":"chatbot-wrapper","html":"\u003Cdiv class=\u0022with-default-orbita-widget\u0022\u003E\r\n  \u003Cbutton class=\u0022chat-widget\u0022 aria-label=\u0022Show Chatbot\u0022\u003E\r\n    \u003Cdiv\u003E\r\n      \u003Cdiv class=\u0022chat-bubble\u0022\u003E\u003C\/div\u003E\r\n      \u003Cp\u003EChat\u003C\/p\u003E\r\n    \u003C\/div\u003E\r\n  \u003C\/button\u003E\r\n\u003C\/div\u003E","css":""},"modal":{"description":"To open the live chat we need your permission to contact Orbita. This allows us to place a live chat widget on the page.","consent_label":"Allow Orbita live chat","morelink_label":"","morelink_url":""}}},"user":{"uid":0,"permissionsHash":"9ce7e3d0a53d6f666750a985c111fdd22308fb0fdb5f15c0fdda00c8dcaa54f4"}}</script>
<script src="../sites/g/files/qhldwo11641/files/js/optimized/js_dxIVcwvQ00owLGoUGPTfRYXU-T5rnj8Xi0cXfb3Kn58._JqT3SQfawRcv_BIHPThkBvs0OEvtFFmqPF_lYI_Cxod734.js?v=3.7.1"></script>
<script src="../sites/g/files/qhldwo11641/files/js/optimized/js_w0iO3No0CsyHgJmryEbhwpkh5zx6m6dhvawBt4ufwyA.HRN_m4FplP890kDvBJQuv0fEgTHDKwrMZA2zBldV1JYf700.js?v=1.0.1"></script>
<script src="../sites/g/files/qhldwo11641/files/js/optimized/js_Hpe5jrMuKXrV4HSTMApXJsNBxraAgcHUrTjxkwWKqy8.9H1W9OQqD9V27idEVOJMCFAQtGS4Scq-gAQciKr0U2Mfe04.js?v=10.5.0"></script>
<script src="../sites/g/files/qhldwo11641/files/js/optimized/js_V1oRQ-kJlXBZaEklOtPUe_1t8-l0RS94HJ3gsqxKikc.LMtm7OsF5tFcpxpmBexOddu30l-Xz-FUCSBPovfiEt8fe04.js?v=10.5.0"></script>
<script src="../sites/g/files/qhldwo11641/files/js/optimized/js_KRjtvzl6UujB23-j_sF6dqOcbqg2z8ej98A8RU9bGsg.kjk12BMQYgWzHTlTsh40oAfzJ1jsDD0rpt092h-M9ukfe04.js?v=10.5.0"></script>
<script src="../sites/g/files/qhldwo11641/files/js/optimized/js_rJQeYB7caXNCdmgzJ4t5f6f6CrVuk9_CJlqK8yDBzqk.QLD7mKey3phzumqz3uRKIHY2nqqKo_plzIfGrgeQ5Ycfe04.js?v=10.5.0"></script>
<script src="../sites/g/files/qhldwo11641/files/js/optimized/js_pbrt6BW6zk2scxcVck6pKOhrsnS-4n6mdUeoPTfK2aM.F15X2YCXNVRiXJFw9bAWTN9GXU1HaAbvYHvOoFmnbLUfe04.js?v=10.5.0"></script>
<script src="../sites/g/files/qhldwo11641/files/js/optimized/js_CbOM1f2ZQjSvD29Vzs3nHYsIjSyprydKvJ38uk-EKzQ.dAXI56pV2ZPn9QGfyd-mmPdBCd_VlavLN59BjPAgNOgfe04.js?v=10.5.0"></script>
<script src="../sites/g/files/qhldwo11641/files/js/optimized/js_1_Qr-HDXqlP8qV9oE0Levmwx3Sc1ldDn6Q9QvWEYY6E.XXTdDFNiWNbao5RRs1Aq-_G2fwGOGtyrrBgSr48Pr6wfe04.js?v=10.5.0"></script>
<script src="../sites/g/files/qhldwo11641/files/js/optimized/js_yt_B6-UYT74y4dRKoGQ9gfLb0O0RDb4vG2LIGOYlHq8.-UGjQblMTO_e3Grk02Go8eAWHwbL6GT0oAl-h-CgK5Qfe04.js?v=10.5.0"></script>
<script src="../sites/g/files/qhldwo11641/files/js/optimized/js_OYMUXIYk_UxVlsQSqo3_hSK3aC6qbx7cz9wNrtTse48.D7Do9Gn7KAOch1JHc7ma8CZHkvZvUTPAc5nIoo3LX44fe04.js?v=10.5.0"></script>
<script src="../sites/g/files/qhldwo11641/files/js/optimized/js_A7R00KDzeuDMEsk6DOs_s2ZrOjO5c23zgXuffR4Khqc.q6qxxfVF7-gZME3a3JPerO2q6sv01F6mQnVPwcmknYofe04.js?v=10.5.0"></script>
<script src="../sites/g/files/qhldwo11641/files/js/optimized/js_4VhSX4lEyBg9lxgOnT6eUHtdfwq4GgGv6TSm_aWIhzc.msJZjs5u5RGmKA2fbhFxLGexUv1x2UOibCSs8rzkw1Ufe04.js?v=10.5.0"></script>
<script src="../sites/g/files/qhldwo11641/files/js/optimized/js_VycJ3FTVVaVyhSCcLXYEaSJoilQ8WxeImUFAjqgR5Y8.ouOM0Q5oYPfUBV8lTR3cCyJG56DQNwRTOVgi8IFXBrAfe04.js?v=10.5.0"></script>
<script src="../sites/g/files/qhldwo11641/files/js/optimized/js_QZ6R3WHZ2xvc16JcQ7QBGg7ZW5Q69JxQSKxhelKIbIE.rnfvk6uzW1ISnGjxzePWaH83MAcUkTOsSGF6xij2QAsfe04.js?v=10.5.0"></script>
<script src="../sites/g/files/qhldwo11641/files/js/optimized/js_SpWiM_QFpYbnP3qrlmV1Aa2OGQVC1G0okd3jErKS1EI.Cz8_DwPQcpJrjdTZvBKdqWS7V0abyjGDgrVg6Diy3jkfe04.js?v=10.5.0"></script>
<script src="../sites/g/files/qhldwo11641/files/js/optimized/js_shtMqRNOVBaAvLi9-CpiCI1loPsDLJlEM8e0qdxIyaA._ljAZbtHeBUPsD_JTpPHK9XLnZ-Bh8IIR0gfaERLf0kfe04.js?v=10.5.0"></script>
<script src="../sites/g/files/qhldwo11641/files/js/optimized/js_J05cWfCFFxc6Ntk7FqEMfp2MqvFE0LYhqPR-d5pkpX4.eRBP0BbEW9K4axpZn5GrBrvbQysogv9ziF_qly6y9P0fe04.js?v=10.5.0"></script>
<script src="../sites/g/files/qhldwo11641/files/js/optimized/js_XrfmCmDqLTCEPh8gnU8hVIYf5mJPXNeZp91Zu1g8f9Y.i3qujr4t4NUUzwk0bY4rUPAZgLDWLpH4I0Ht5U7c2Gsfe04.js?v=10.5.0"></script>
<script src="../sites/g/files/qhldwo11641/files/js/optimized/js_DB1pt9EyFJ14MM4u0q_UUdhcwWPwrgl0M8Ao_U1cQKw.1HGXCu8xDCZ9D4t4OUEJBVbpMoVuuCDmld0Orcde48Ufe04.js?v=10.5.0"></script>
<script src="../sites/g/files/qhldwo11641/files/js/optimized/js_xTMVqsdfgSLZsrDVnB0yeJ_u8fjPX7MQHI1nVihqNuE.7B-a0BsG-0oGVyrcfb37AxOKeNquBdl8lk3CyiHXfeUfe04.js?v=10.5.0"></script>
<script src="../sites/g/files/qhldwo11641/files/js/optimized/js_gEmjNg-vrsVI816UzVFe6X3vlSx0FTpPgKUR0axgrXs.aT1b17yuuFOZ02MCX5ONYrorBiyoVdHn6EFMtlXyDCAfe04.js?v=10.5.0"></script>
<script src="../sites/g/files/qhldwo11641/files/js/optimized/js_trjIfy6wGxnxz9PVSI8rA84dA6HxX_Lw5W4uUlw0Xs0.-KbTIsNarrWDUf2UHG7fElVJxl72-Pmuf_1NbApB5A0fe04.js?v=10.5.0"></script>
<script src="../sites/g/files/qhldwo11641/files/js/optimized/js_2hr-YHySYMDuptPCwhH1H7CfNShEa93koPpOo_581D4.fU-RbWLSh2I8Ytqntu1-ArKZ9OVXly0tO-X8U0Ety6Ife04.js?v=10.5.0"></script>
<script src="../sites/g/files/qhldwo11641/files/js/optimized/js_WmhavmnC0K35xZ9vLX51qtRqFT74puvZXIMWnNUYpbM.HmKlReEYCiV9GnfhxV81WuXqMJ6i6CJEQgYJrzlXRtw0559.js?v=6.2.0"></script>
<script src="../sites/g/files/qhldwo11641/files/js/optimized/js_pCqeI411sVqMjF7f2fKhUUOV4yKaxxQp7FHSELuxGGc.2g5bmie0CWfVbbOg32zvwXHEUfmS0mqFc0I_Z7vrtvMfe04.js?v=10.5.0"></script>
<script src="../modules/contrib/adobe_launch/js/adobe_launch_dtm_init1cee.js?t5xpr9"></script>
<script src="../modules/contrib/google_tag/js/gtag1cee.js?t5xpr9"></script>
<script src="../sites/g/files/qhldwo11641/files/js/optimized/js_1woVuTYaOTc9db19BvtYERQ-r3zrWbaX8Iy9t_Z2qoM.pMTBYmavvxWwegzqwJmMmmYVLsQ3cxiWBi9yq_dxzNMe0a5.js?v=4.3.0"></script>
<script src="../sites/g/files/qhldwo11641/files/js/optimized/js_mjv4qhOv2_1-EQeYpZwvWqHcMokP3Cu36uHh9tRNXFY.CJF84Dv0PjH3KPaqgwzS-NJS45qPbXaVePB7UAw-uH8fe04.js?v=10.5.0"></script>
<script src="../sites/g/files/qhldwo11641/files/js/optimized/js_ezwJb8QjKN82W11Y2widYXtFt5DfOo-fgZxIg_9sAik.s0ftg9DcYKonxRNsyujPK8mZFoHu6DwZvsB0967odSIfe04.js?v=10.5.0"></script>
<script src="../modules/contrib/google_tag/js/gtm1cee.js?t5xpr9"></script>
<script src="../sites/g/files/qhldwo11641/themes/site/themes/custom/jynarque_hcp/legacy/assets/build/js/components/isi-state1cee.js?t5xpr9" defer></script>
<script src="../sites/g/files/qhldwo11641/files/js/optimized/js_J_G6YrAi5duRDJekzJ6rjnG28oqOVCu_MPQwxhSYGow.Qp9BFfZG_BWtt9YimvmtE9BSWD3fWWQmE_KLI5Eoiao1cee.js?t5xpr9"></script>
<script src="../sites/g/files/qhldwo11641/files/js/optimized/js_dgim6OgqTA_DG5wPkPdSGk_ffzUkd8ip9LwuHxVo1sI.mZ98qx_1nQtXzgDDy9reKJSzFDoo-w4yhyIdEfKAHlM1cee.js?t5xpr9"></script>
<script src="../sites/g/files/qhldwo11641/files/js/optimized/js_q7FJqCr4JCiQip_Tz2e_h4tgMP443SG2ovYc1mDfmhQ.pnyD-CkIhe1h_Jx0jtDrfSNlPJAqzILWsJ3NvZYdOtI1cee.js?t5xpr9"></script>
<script src="../sites/g/files/qhldwo11641/files/js/optimized/js_aEkVIYuSMtGvUpkRLpsx4Havd-U7CgaBzI4c8T043hY.bNn0IFRdhaUJdh1PX_eJXXz5xx_slAb_npV-mqLhAyw1cee.js?t5xpr9"></script>
<script src="../sites/g/files/qhldwo11641/themes/site/themes/custom/jynarque_hcp/legacy/assets/build/js/components/isi-resize1cee.js?t5xpr9" defer></script>
<script src="../sites/g/files/qhldwo11641/themes/site/themes/custom/jynarque_hcp/legacy/assets/build/js/base/bootstrap/bootstrapcd33.js?v=4.5.2" defer></script>
<script src="../sites/g/files/qhldwo11641/files/js/optimized/js_P-oMcsV1isPQN7J_9srX5flt9fqyRhUBLJFfnVUO7_8.Uf0TeQfB8iU5YkLJufFdWdXZs7P4QlCa9W649PI35-k1cee.js?t5xpr9"></script>
<script src="../sites/g/files/qhldwo11641/files/js/optimized/js_OS7umhC2npk_k6HFrTBUOGw7IMkQkSTpjJrtCzMIIFU.mjh9oGk3WVOVcHsF6kJLjqansWN1KLh7O_3yd4FDBmg1cee.js?t5xpr9"></script>
<script src="../sites/g/files/qhldwo11641/files/js/optimized/js_bxDZKA71LpajHuuDs_IsmHcULV4iGZ5wDebNISM68Ec.QOaAi5jgG26lpVuvuNRQ1BkxXXJdSqieBPgIZrXkS9M1cee.js?t5xpr9"></script>
<script src="../sites/g/files/qhldwo11641/themes/site/themes/custom/jynarque_hcp/legacy/assets/build/js/components/jynarque/jynarque_custom1cee.js?t5xpr9" defer></script>
<script src="../sites/g/files/qhldwo11641/themes/site/themes/custom/jynarque_hcp/legacy/assets/build/js/components/mainmenu1cee.js?t5xpr9" defer></script>
<script src="../sites/g/files/qhldwo11641/themes/site/themes/custom/jynarque_hcp/legacy/assets/build/js/components/anchor-scroll1cee.js?t5xpr9" defer></script>
<script src="../sites/g/files/qhldwo11641/themes/site/themes/custom/jynarque_hcp/legacy/assets/build/js/components/video-react1cee.js?t5xpr9" defer></script>
<script src="../sites/g/files/qhldwo11641/files/js/optimized/js_nKlW0s1eP3bGjyfbSHP4guHgnuCQ2V_IbkgMZ4UdzO4.MTHCcdAQ1524jW6nLa3EtNqF_1TujsKyr8qksEY7n6wfe04.js?v=10.5.0"></script>
<script src="../sites/g/files/qhldwo11641/files/js/optimized/js_KKcnkUdYKB53TMNVsf6RrHXCgsIpqtdkf2utxTGblLc.ynu_A6j2Wzd1B6Vw6BTQ8qyocstdbrEa04BlYLcbHiEfe04.js?v=10.5.0"></script>
<script src="../sites/g/files/qhldwo11641/files/js/optimized/js_3V5UYvHeGVCTCI6-0G9MShZMkOTjpmWzauUa17REJYg.Skr0Jc5GUKefc-pdZvCEo932Y2orIBO4a5uHTzer7YMfe04.js?v=10.5.0"></script>
<script src="../sites/g/files/qhldwo11641/files/js/optimized/js_7SLROedAOygMVqhG50yRRbiZ1w7AmAy9Wx63Se_hrEo.RHHoh3qOJXKfC_izkCzBQeHAM9lKs2tMLnwwXJQddecfe04.js?v=10.5.0"></script>
<script src="../sites/g/files/qhldwo11641/files/js/optimized/js_3PPDECkkWmZprRXP5fGfqH5tOkTJcwB21__r7fjPUh4.FM0QEgk5sXswUR2j_HZSngwH1zEUr0v2J8mHf-3nglsfe04.js?v=10.5.0"></script>
<script src="../sites/g/files/qhldwo11641/files/js/optimized/js_GrQl3TMVBdSFgif7bkvIVoCWbf9SY3sm8jianc5MBYI.a7xJmtDE8RvIy3x-q9FvAIJ1W6CbYZd3rd0FQNL3Q-sfe04.js?v=10.5.0"></script>
<script src="../sites/g/files/qhldwo11641/files/js/optimized/js_4bZGp8eSSkr0AcYEB06FWt2zMZLqDhKxz6gEhKnO5X0.-_wJjs2BWnIoDstNCjVUMdohPAm1Cb6KMFLzNQnyetsfe04.js?v=10.5.0"></script>
<script src="../sites/g/files/qhldwo11641/files/js/optimized/js_dOdL6MKe8Xi7Kps6emaAgxWRpDXYc7U7glpIUKIBOiA.XAp-Kcb5FZvnj1DJvOdVsSEE04SX1ckhOvPcQwTj6hofe04.js?v=10.5.0"></script>
<script src="../sites/g/files/qhldwo11641/files/js/optimized/js_YSBqDrGfkyMrsn-wT-lty4BnE7uEji7vl0zKC_-Z0BE.oLTnTHb9AUCZyGIMu_xYoE6Miz_LA_c24mSOzHiEwxUfe04.js?v=10.5.0"></script>
<script src="../sites/g/files/qhldwo11641/files/js/optimized/js__TF0_87cNnB7zfFuH5jalW1RMKzKj__FtRNXnDln7eA.LbmYeeNvT-Bo1K2wExK2EJO_Hm8zkO7p3Daf1NdLzbMfe04.js?v=10.5.0"></script>

  </head>
  
  <body class="isi-enabled isi-drawer-enabled custom-page--adpkd-about section--0-adpkd section--1-about path-node page-node-type-brand-basic-page page-node-25846">
    <div class="content-wrapper">
        <div role="navigation" aria-label="Skip to main content">
      <a href="#main-content" class="visually-hidden focusable skip-link">
        Skip to main content
      </a>
    </div>
    
<header role="banner" id="header-wrap" class="menu-section">
    <div class="header-container">
      <div class="header-left">
        <div class="header-branding">
          <a href="../index.html" data-test="navbar-logo" 
            data-analytics-link='{"name":"company logo","position":"header","group":"Logo","href":"https://www.jynarquehcp.com/"}' 
          ><img src="../sites/g/files/qhldwo11641/themes/site/themes/custom/jynarque_hcp/legacy/assets/build/img/jynarque-logo.png" alt="JYNARQUE速 (tolvaptan), Logo"></a>
        </div>
        <a href="#" class="off-canvas-button" 
          data-analytics-link='{"name":"Navbar Toggle","position":"header","group":"Logo","href":"https://www.jynarquehcp.com/"}' 
          data-test='mobile-menu-toggle'
        ></a>
      </div>
      <div class="header-right">
        <div class="header-intended-audience">
            <div class="region region-header-intended-audience">
    <nav role="navigation" aria-labelledby="block-utilitynav-menu" id="block-utilitynav" class="custom-block--utilitynav">
            
  <div class="visually-hidden" id="block-utilitynav-menu">Utility Nav</div>
  

        
              <ul block="block-utilitynav" region="header_intended_audience" data-test="top-menu">
              <li>
                <a href="https://www.otsuka-us.com/media/static/JYNARQUE-PI.pdf" target="_blank" class="ssp-bold mobile-separator prominent reverse-yellow mobile-shift external-link-popup-disabled">U.S. FULL PRESCRIBING INFORMATION,<br /> INCLUDING BOXED WARNING</a>
              </li>
          <li>
                <a href="#isi-top" target="_self" class="isi-jump-link ssp-bold prominent important-safety-information-link">Important Safety Information</a>
              </li>
          <li>
                <a href="https://www.jynarque.com/" target="_self" class="ssp-bold mobile-hide ext-link prominent patient-site-link ssp-bold mobile-hide ext-link prominent patient-site-link">Patient Site</a>
              </li>
          <li>
                <span>This site is intended for U.S. Healthcare Professionals only</span>
              </li>
        </ul>
  


  </nav>

  </div>

        </div>
        <div class="header-main-menu">
            <div class="region region-header-main-menu">
    <nav role="navigation" aria-labelledby="block-jynarque-hcp-main-menu-menu" id="block-jynarque-hcp-main-menu" class="custom-block--jynarque-hcp-main-menu">
            
  <div class="visually-hidden" id="block-jynarque-hcp-main-menu-menu">Main navigation</div>
  

        

              <ul block="block-jynarque-hcp-main-menu" region="header_main_menu" class="menu nav" data-test='main-menu'>
                          <li class="menu-item">
                                                            <a href="../index.html" class="home-link" data-analytics-link="{&quot;name&quot;:&quot;Home&quot;,&quot;position&quot;:&quot;header&quot;,&quot;group&quot;:&quot;main-menu&quot;,&quot;href&quot;:&quot;https://www.jynarquehcp.com/&quot;}" data-drupal-link-system-path="&lt;front&gt;">Home</a>
        
        
        
        
              </li>
                      <li class="menu-item menu-item--expanded menu-item--active-trail">
                                                            <span target="_self" class="understanding-link data-analytics-click-link" role="button" data-analytics-link="{&quot;name&quot;:&quot;Understanding ADPKD&quot;,&quot;position&quot;:&quot;header&quot;,&quot;group&quot;:&quot;main-menu&quot;,&quot;href&quot;:&quot;n/a&quot;}">Understanding ADPKD</span>
        
        
                  <div class="menu-toggle"></div>
        
        
                                <ul class="menu sub-nav">
                          <li class="menu-item menu-item--active-trail">
                                                            <a href="about.html" data-analytics-link="{&quot;name&quot;:&quot;About ADPKD&quot;,&quot;position&quot;:&quot;header&quot;,&quot;group&quot;:&quot;main-menu&quot;,&quot;href&quot;:&quot;n/a&quot;}" data-drupal-link-system-path="node/25846" class="is-active" aria-current="page">About ADPKD</a>
        
        
        
        
              </li>
                      <li class="menu-item">
                                                            <a href="progression.html" target="_self" data-analytics-link="{&quot;name&quot;:&quot;Disease progression&quot;,&quot;position&quot;:&quot;header&quot;,&quot;group&quot;:&quot;main-menu&quot;,&quot;href&quot;:&quot;https://www.jynarquehcp.com/adpkd/progression&quot;}" data-drupal-link-system-path="node/2">Disease progression</a>
        
        
        
        
              </li>
                      <li class="menu-item">
                                                            <a href="../measuring-tkv-for-ckd-staging.html" data-analytics-link="{&quot;name&quot;:&quot;Measuring kidney size&quot;,&quot;position&quot;:&quot;header&quot;,&quot;group&quot;:&quot;main-menu&quot;,&quot;href&quot;:&quot;https://www.jynarquehcp.com/measuring-tkv-for-ckd-staging&quot;}" data-drupal-link-system-path="node/9">Measuring kidney size</a>
        
        
        
        
              </li>
        </ul>
  
              </li>
                      <li class="menu-item">
                                                            <a href="../mechanism-of-action.html" class="mechanism-of-action-link nav-desktop-only" data-analytics-link="{&quot;name&quot;:&quot;Mechanism of Action&quot;,&quot;position&quot;:&quot;header&quot;,&quot;group&quot;:&quot;main-menu&quot;,&quot;href&quot;:&quot;https://www.jynarquehcp.com/mechanism-of-action&quot;}" data-drupal-link-system-path="node/4">Mechanism of Action</a>
        
        
        
        
              </li>
                      <li class="menu-item menu-item--collapsed">
                                                            <span class="efficacy-link data-analytics-click-link" role="button" data-analytics-link="{&quot;name&quot;:&quot;Efficacy&quot;,&quot;position&quot;:&quot;header&quot;,&quot;group&quot;:&quot;main-menu&quot;,&quot;href&quot;:&quot;n/a&quot;}">Efficacy</span>
        
        
                  <div class="menu-toggle"></div>
        
        
                                <ul class="menu sub-nav">
                          <li class="menu-item">
                                                            <a href="../clinical-trial-efficacy.html" data-analytics-link="{&quot;name&quot;:&quot;Pivotal trials&quot;,&quot;position&quot;:&quot;header&quot;,&quot;group&quot;:&quot;main-menu&quot;,&quot;href&quot;:&quot;https://www.jynarquehcp.com/clinical-trial-efficacy&quot;}" data-drupal-link-system-path="node/25991">Pivotal trials</a>
        
        
        
        
              </li>
                      <li class="menu-item">
                                                            <a href="../non-pivotal-data.html" data-analytics-link="{&quot;name&quot;:&quot;Non-pivotal data&quot;,&quot;position&quot;:&quot;header&quot;,&quot;group&quot;:&quot;main-menu&quot;,&quot;href&quot;:&quot;https://www.jynarquehcp.com/non-pivotal-data&quot;}" data-drupal-link-system-path="node/26061">Non-pivotal data</a>
        
        
        
        
              </li>
        </ul>
  
              </li>
                      <li class="menu-item menu-item--collapsed">
                                                            <span target="_self" class="safety-link data-analytics-click-link" role="button" data-analytics-link="{&quot;name&quot;:&quot;Safety Profile&quot;,&quot;position&quot;:&quot;header&quot;,&quot;group&quot;:&quot;main-menu&quot;,&quot;href&quot;:&quot;n/a&quot;}">Safety Profile</span>
        
        
                  <div class="menu-toggle"></div>
        
        
                                <ul class="menu sub-nav">
                          <li class="menu-item">
                                                            <a href="../clinical-information/safety-profile.html" data-analytics-link="{&quot;name&quot;:&quot;Safety profile&quot;,&quot;position&quot;:&quot;header&quot;,&quot;group&quot;:&quot;main-menu&quot;,&quot;href&quot;:&quot;https://www.jynarquehcp.com/clinical-information/safety-profile&quot;}" data-drupal-link-system-path="node/5">Safety profile</a>
        
        
        
        
              </li>
                      <li class="menu-item">
                                                            <a href="../clinical-information/open-label-extension-study.html" data-analytics-link="{&quot;name&quot;:&quot;Open-label extension study&quot;,&quot;position&quot;:&quot;header&quot;,&quot;group&quot;:&quot;main-menu&quot;,&quot;href&quot;:&quot;https://www.jynarquehcp.com/clinical-information/open-label-extension-study&quot;}" data-drupal-link-system-path="node/26066">Open-label extension study</a>
        
        
        
        
              </li>
        </ul>
  
              </li>
                      <li class="menu-item">
                                                            <a href="../rems-program.html" class="rems-link" data-analytics-link="{&quot;name&quot;:&quot;REMS&quot;,&quot;position&quot;:&quot;header&quot;,&quot;group&quot;:&quot;main-menu&quot;,&quot;href&quot;:&quot;https://www.jynarquehcp.com/rems-program&quot;}" data-drupal-link-system-path="node/7">REMS</a>
        
        
        
        
              </li>
                      <li class="menu-item menu-item--collapsed">
                                                            <span class="identifying-counseling-patients-link data-analytics-click-link" role="button" data-analytics-link="{&quot;name&quot;:&quot;Identifying and Counseling Patients&quot;,&quot;position&quot;:&quot;header&quot;,&quot;group&quot;:&quot;main-menu&quot;,&quot;href&quot;:&quot;n/a&quot;}">Identifying and Counseling Patients</span>
        
        
                  <div class="menu-toggle"></div>
        
        
                                <ul class="menu sub-nav">
                          <li class="menu-item">
                                                            <a href="../identify-patients.html" data-analytics-link="{&quot;name&quot;:&quot;Patient identification&quot;,&quot;position&quot;:&quot;header&quot;,&quot;group&quot;:&quot;main-menu&quot;,&quot;href&quot;:&quot;https://www.jynarquehcp.com/identify-patients&quot;}" data-drupal-link-system-path="node/38836">Patient identification</a>
        
        
        
        
              </li>
                      <li class="menu-item">
                                                            <a href="../patient-profiles.html" data-analytics-link="{&quot;name&quot;:&quot;Patient profiles&quot;,&quot;position&quot;:&quot;header&quot;,&quot;group&quot;:&quot;main-menu&quot;,&quot;href&quot;:&quot;https://www.jynarquehcp.com/patient-profiles&quot;}" data-drupal-link-system-path="node/26016">Patient profiles</a>
        
        
        
        
              </li>
                      <li class="menu-item">
                                                            <a href="../patient-counseling.html" class="patient-counseling-link Patient Counseling" data-analytics-link="{&quot;name&quot;:&quot;Patient counseling&quot;,&quot;position&quot;:&quot;header&quot;,&quot;group&quot;:&quot;main-menu&quot;,&quot;href&quot;:&quot;https://www.jynarquehcp.com/patient-counseling&quot;}" data-drupal-link-system-path="node/38851">Patient counseling</a>
        
        
        
        
              </li>
        </ul>
  
              </li>
                      <li class="menu-item">
                                                            <a href="../dosing-information.html" class="dosing-link nav-desktop-only" data-analytics-link="{&quot;name&quot;:&quot;Dosing&quot;,&quot;position&quot;:&quot;header&quot;,&quot;group&quot;:&quot;main-menu&quot;,&quot;href&quot;:&quot;https://www.jynarquehcp.com/dosing-information&quot;}" data-drupal-link-system-path="node/6">Dosing</a>
        
        
        
        
              </li>
                      <li class="menu-item menu-item--collapsed">
                                                            <span class="resources-link data-analytics-click-link" role="button" data-analytics-link="{&quot;name&quot;:&quot;Resources&quot;,&quot;position&quot;:&quot;header&quot;,&quot;group&quot;:&quot;main-menu&quot;,&quot;href&quot;:&quot;n/a&quot;}">Resources</span>
        
        
                  <div class="menu-toggle"></div>
        
        
                                <ul class="menu sub-nav">
                          <li class="menu-item">
                                                            <a href="../expert-videos.html" data-analytics-link="{&quot;name&quot;:&quot;Video library&quot;,&quot;position&quot;:&quot;header&quot;,&quot;group&quot;:&quot;main-menu&quot;,&quot;href&quot;:&quot;https://www.jynarquehcp.com/expert-videos&quot;}" data-drupal-link-system-path="node/38816">Video library</a>
        
        
        
        
              </li>
                      <li class="menu-item">
                                                            <a href="../treatment-resources.html" data-analytics-link="{&quot;name&quot;:&quot;Treatment resources&quot;,&quot;position&quot;:&quot;header&quot;,&quot;group&quot;:&quot;main-menu&quot;,&quot;href&quot;:&quot;https://www.jynarquehcp.com/treatment-resources&quot;}" data-drupal-link-system-path="node/38831">Treatment resources</a>
        
        
        
        
              </li>
                      <li class="menu-item">
                                                            <a href="../clinical-resources.html" data-analytics-link="{&quot;name&quot;:&quot;Clinical resources&quot;,&quot;position&quot;:&quot;header&quot;,&quot;group&quot;:&quot;main-menu&quot;,&quot;href&quot;:&quot;https://www.jynarquehcp.com/clinical-resources&quot;}" data-drupal-link-system-path="node/38826">Clinical resources</a>
        
        
        
        
              </li>
        </ul>
  
              </li>
        </ul>
  


  </nav>

  </div>

        </div>
      </div>
    </div>
</header>

    <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-W8LVZL2"
                  height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>

      <div class="dialog-off-canvas-main-canvas" data-off-canvas-main-canvas>
    <div  class="layout-container" >

  
    <div class="region region-messages">
    <div data-drupal-messages-fallback class="hidden"></div>

  </div>


  <main role="main">
    <a id="main-content" tabindex="-1"></a>
          <div class="layout-pre-content">
          <div class="region region-pre-content">
    <div class="views-element-container custom-block--views-block__custom-page-title-custom-page-title" id="block-views-block-custom-page-title-custom-page-title">
  
    
      <div><div class="js-view-dom-id-4d628deb697e4c522b1f751a7e8c897aabc1b26c69de4b649c47ae94437ae5f5">
  
  
  

  
  
  

      <div class="views-row"><div class="views-field views-field-field-headline"><h1 class="field-content page-title">ADPKD is a genetic, progressive disease<sup>1,2</sup>
</h1></div></div>

    

  
  

  
  
</div>
</div>

  </div>

  </div>

      </div>
    
    <div class="layout-content content-wrap-outer">
          <div class="region region-content">
    <div id="block-jynarque-hcp-content" class="custom-block--jynarque-hcp-content">
  
    
      

<article class="custom--adpkd-about region-with-right-sidebar">

  <section class="node-wrapper">
    
    
    <div class="container">
      <div class="row">
                  <div class="col-md-10 col-lg-7">
            <div class="node-content">
              


                    
  <div class="clearfix paragraph paragraph--type--pharma-copy-region paragraph--view-mode--default" id="paragraph-921" data-test='paragraph'>
          


                    <div class="field_pharma_body_copy "><h2>Autosomal dominant polycystic kidney disease (ADPKD) is characterized by the continuous development and enlargement of cysts in the kidneys<sup>1,2</sup></h2>

<p>A parent with ADPKD has a 50% chance of passing the disease on to each of their children.<sup>3,4</sup></p>

<div class="kidney-4x-wrapper">
<h3>Over time, enlarging cysts can increase kidney size by up to 4 times that of normal kidneys<sup>5</sup></h3>

<ul>
	<li>Enlarging cysts contribute to the compression and loss of surrounding functional renal tissue, resulting in a progressive decline of renal function<sup>1,6</sup></li>
	<li>The damage caused by enlarging cysts and the increase in kidney size become irreversible, which eventually leads to end-stage kidney disease (ESKD)<sup>6</sup></li>
</ul>
</div>

<div class="signs-symptoms-section">
<h2>signs and symptoms of ADPKD can be difficult to identify</h2>

<p>Although ADPKD is a genetic disease, family history may be unknown. When patients experience symptoms related to ADPKD, the disease may not be promptly recognized. As a result, years can elapse before the diagnosis of ADPKD is made.<sup>3,4</sup></p>

<h3>ADPKD is a heterogeneous renal disease with a high degree of symptom <span class="nowrap">variability<sup>3,7-10</sup></span></h3>
</div>
</div>
            
      </div>

                              


        <div class="clearfix paragraph content-box full-width inline-image paragraph-2236" data-test='paragraph'>
                      <div class="desktop-only tablet-only">
        


                    <div class="field_pharma_graphic ">  <img loading="eager" src="../sites/g/files/qhldwo11641/files/2022-05/adpkd-renal-extra-renal-manifestations.png" width="371" height="291" alt="Renal and Extra-Renal Manifestations in Patients with ADPKD" />

</div>
            
        </div>
        <div class="mobile-only">
        


                    <div class="field_pharma_graphic_mobile_alt ">  <img loading="eager" src="../sites/g/files/qhldwo11641/files/adpkd-renal-extra-renal-manifestations-mobile_0.png" width="282" height="288" alt="Renal and Extra-Renal Manifestations in Patients with ADPKD" />

</div>
            
        </div>
                  </div>
    
                              
  <div class="clearfix paragraph paragraph--type--pharma-copy-region paragraph--view-mode--default" id="paragraph-931" data-test='paragraph'>
          


                    <div class="field_pharma_body_copy "><ul class="body-graphic-caption">
	<li>Hepatic cysts are the most common <span class="nowrap">extra-renal</span> manifestation in patients with ADPKD<sup>3</sup></li>
</ul>
</div>
            
      </div>

                                      <div class="clearfix paragraph section-break">
    </div>
    
                              
  <div class="clearfix paragraph paragraph--type--pharma-copy-region paragraph--view-mode--default" id="paragraph-2201" data-test='paragraph'>
          


                    <div class="field_pharma_body_copy "><h2 id="diagnosing-adpkd-slash-other-factors-to-consider-scroll-anchor">OTHER FACTORS TO CONSIDER WHEN DIAGNOSING ADPKD</h2></div>
            
      </div>

                              
  <div class="clearfix external-list paragraph paragraph--type--pharma-copy-region paragraph--view-mode--default" id="paragraph-2206" data-test='paragraph'>
          


                    <div class="field_pharma_body_copy "><div class="criteria-caption-wrapper">
<p>Even though ADPKD impacts all races, research shows that patient outcomes, such as early diagnosis and treatment of ADPKD, may vary by race and ethnicity attributed to social determinants of health (SDOH). Though more extensive research is needed, based on the available data, it's important to consider the following:</p>

<ul>
	<li>Other conditions that are more common in Black patients with ADPKD, such as hypertension, diabetes, or sickle cell, have the potential to mask an ADPKD diagnosis<sup>11</sup></li>
</ul>
</div>
</div>
            
      </div>

                                      <div class="clearfix paragraph section-break">
    </div>
    
                              
  <div class="clearfix paragraph paragraph--type--pharma-copy-region paragraph--view-mode--default" id="paragraph-941" data-test='paragraph'>
          


                    <div class="field_pharma_body_copy "><h2>DIAGNOSING ADPKD</h2><h3>Multiple techniques can be used to confirm a diagnosis of ADPKD<sup>12</sup></h3><p>Diagnosis of ADPKD is typically established on the basis of:</p></div>
            
      </div>

                              


        <div class="clearfix family-history-graphic paragraph content-box full-width inline-image paragraph-946" data-test='paragraph'>
                      <div class="desktop-only tablet-only">
        


                    <div class="field_pharma_graphic ">  <img loading="eager" src="../sites/g/files/qhldwo11641/files/2020-09/adpkd-positive-family-history-diagnosis-imaging-studies.png" width="374" height="125" alt="" />

</div>
            
        </div>
        <div class="mobile-only">
        


                    <div class="field_pharma_graphic_mobile_alt ">  <img loading="eager" src="../sites/g/files/qhldwo11641/files/adpkd-positive-family-history-diagnosis-imaging-studies-mobile.png" width="323" height="373" alt="" />

</div>
            
        </div>
                  </div>
    
                              
  <div class="clearfix paragraph paragraph--type--pharma-copy-region paragraph--view-mode--default" id="paragraph-2216" data-test='paragraph'>
          


                    <div class="field_pharma_body_copy "><h3>Ultrasound is the most commonly used imaging modality for a diagnosis of ADPKD<sup>13</sup></h3>

<p class="blue-image-caption">Unified ultrasonographic criteria for diagnosis of ADPKD in patients with positive family history (Pei criteria)<sup>14,15*</sup>:</p>
</div>
            
      </div>

                              


        <div class="clearfix paragraph content-box full-width inline-image paragraph-956" data-test='paragraph'>
                      <div class="desktop-only tablet-only">
        


                    <div class="field_pharma_graphic ">  <img loading="eager" src="../sites/g/files/qhldwo11641/files/2025-06/adpkd-criteria.png" width="506" height="140" alt="ADPKD Criteria" />

</div>
            
        </div>
        <div class="mobile-only">
        


                    <div class="field_pharma_graphic_mobile_alt ">  <img loading="eager" src="../sites/g/files/qhldwo11641/files/adpkd-criteria-mobile.png" width="318" height="628" alt="ADPKD Criteria" />

</div>
            
        </div>
                  </div>
    
                              
  <div class="clearfix external-list paragraph paragraph--type--pharma-copy-region paragraph--view-mode--default" id="paragraph-2221" data-test='paragraph'>
          


                    <div class="field_pharma_body_copy "><div class="criteria-caption-wrapper">
<p class="paragraph-blue"><strong>When there is no clear family history:</strong></p>

<ul>
	<li>Genetic testing is available to help confirm a diagnosis</li>
	<li>Multiple factors should be considered, including the age of the patient, presence of associated manifestations (ie, liver cysts), bilaterally enlarged kidneys, and &gt;10 cysts in each kidney<sup>16</sup></li>
</ul>
</div>
</div>
            
      </div>

                              
  <div class="clearfix paragraph paragraph--type--pharma-copy-region paragraph--view-mode--default" id="paragraph-2226" data-test='paragraph'>
          


                    <div class="field_pharma_body_copy "><div class="definitions-footnotes">
<p>ADPKD =autosomal dominant polycystic kidney disease; ESKD=end-stage kidney disease; UTI=urinary tract infection.</p>

<p class="external-definition"><span class="external">*</span>Criteria based on age and cyst count in patients with a positive family history.</p>
</div>
</div>
            
      </div>

                              



    
      <div class="clearfix max-width button-sm paragraph reverse headline cta-next-page-nav" data-test='card'>
        <div class="headline-inner-wrap">
          <div class="linear-link-content">
            <div class="cta-body">
              


                    <div class="field_next_page_description "><p><span class="desktop-break"><span class="mobile-break">Discover how kidney size can be a</span> helpful measure </span>in assessing your patients for disease progression</p>
</div>
            
            </div>
            <div class="cta-link">
              <a 
                class="button " id="cta-966" href="progression.html"
                data-analytics-link='{"name":"LEARN MORE","position":"body","group":"Next page action","href":"https://www.jynarquehcp.com/adpkd/progression"}'
              >
                LEARN MORE
              </a>
            </div>
          </div>
        </div>
      </div>

    

            
              


                    <div class="field_component_references ">    <div class="clearfix paragraph paragraph--type--collapsible-references paragraph--view-mode--default" data-test="reference">
          <p>
        <a 
          aria-controls="collapse-references" aria-expanded="false" data-toggle="collapse" href="#collapse-references"
          data-analytics-link='{"name":"REFERENCES","position":"body","group":"References","href":"n/a"}'
        >
          REFERENCES
        </a>
      </p>
      <div class="collapse" id="collapse-references">
        <ol><li>Patel V, Chowdhury R, lgarashi P. Advances in the pathogenesis and treatment of polycystic kidney disease. <em>Curr Opin Nephrol Hypertens</em>. 2009;18(2):99-106.</li><li>Torres VE, Chapman AB, Devuyst O, et al; for the TEMPO 3:4 Trial Investigators. Tolvaptan in patients with autosomal dominant polycystic kidney disease. <em>N Engl J Med.</em> 2012;367(25):2407-2418.</li><li>Ness B, Stovall K. Current recommendations for treating autosomal dominant polycystic kidney disease. <em>JAAPA.</em> 2016;29(12):24-28.</li><li>Chapman AB. Autosomal dominant polycystic kidney disease: time for a change? <em>J Am Soc Nephrol.</em> 2007;18(5):1399-1407.</li><li>Braun WE. Autosomal dominant polycystic kidney disease: emerging concepts of pathogenesis and new treatments.<em> Cleve Clin J Med.</em> 2009;76(2):97-104.</li><li>Grantham JJ, Mulamalla S, Swenson-Fields KI. Why kidneys fail in autosomal dominant polycystic kidney disease. <em>Nat Rev Nephrol.</em> 2011;7(10):556-566.</li><li>Halvorson CR, Bremmer MS, Jacobs SC. Polycystic kidney disease: inheritance, pathophysiology, prognosis, and treatment. <em>Int J Nephrol Renovasc Dis.</em> 2010;3:69-83.</li><li>Torres VE, Harris PC, Pirson Y. Autosomal dominant polycystic kidney disease.<em> Lancet.</em> 2007;369(9569):1287-1301.</li><li>Torres VE, Harris PC. Autosomal dominant polycystic kidney disease: the last 3 years. <em>Kidney Int.</em> 2009;76(2):149-168.</li><li>Li X, ed. Polycystic Kidney Disease. Brisbane, Australia. Codon Publications; 2015.</li><li>Murphy EL, Dai F, Blount KL, Droher ML, et al. Revisiting racial differences in ESRD due to ADPKD in the United States.<em> BMC Nephrol.</em> 2019;20(1):55.</li><li>Chebib FT, Perrone RD, Chapman AB, et al. A practical guide for treatment of rapidly progressive ADPKD with tolvaptan.<em> J Am Soc Nephrol.</em> 2018;29(10):2458-2470.</li><li>Pei Y, Hwang Y-H, Conklin J, et al. Imaging-based diagnosis of autosomal dominant polycystic kidney disease. <em>J Am Soc Nephrol.</em> 2015;26(3):746-753.</li><li>Pei Y, Obaji J, Dupuis A, et al. Unified criteria for ultrasonographic diagnosis of ADPKD. <em>J Am Soc Nephrol.</em> 2009;20(1):205-212.</li><li>Gaur P, Gedroyc W, Hill P. ADPKDwhat the radiologist should know. <em>Br J Radiol.</em> 2019;92(1098): 20190078.</li><li>Chebib FT, Torres VE. Autosomal dominant polycystic kidney disease: core curriculum 2016. <em>Am J Kidney Dis.</em> 2016;67(5):792-810.</li></ol>
      </div>
      </div>
</div>
            
            </div>
          </div>
          <div class="col-md-10 col-lg-3">
            


                    <div class="field_sidebar_cta ">



  
  
  
      
  
  
  <div class="cta-box cta-box_right-side cta-type-type1" data-test='card' data-analytics-group="Call to action">
    <div class="cta-icon">
      


                    <div class="field_cta_icon ">  <img loading="lazy" src="../sites/g/files/qhldwo11641/files/ctas/cta-adpkd-at-risk-patients.png" width="39" height="46" alt="" />

</div>
            
      
    </div>
    <div class="cta-body">
      


                    <div class="field_cta_body "><p>Learn how to identify adult patients at risk of rapidly progressing ADPKD</p></div>
            
    </div>
          <div class="cta-link">
        <a class="button " id="cta-25891" href="../patient-profiles.html" target="">
          REVIEW PATIENT IDENTIFICATION
        </a>
      </div>
              <div class="cta-link">
        
      </div>
      </div>
  
</div>
            
          </div>
              </div>
    </div>
  </section>

</article>

  </div>

  </div>

    </div>          <div class="layout-post-content">
          <div class="region region-post-content">
    


	<a id="isi-top" name="isi-top"></a>
	<section id="inline-isi-wrapper" class="section isi-section" data-test="isi">
		
		<div class="isi isi-block">
			<div class="isi-inline-title-wrap"><span class="isi-block-title"><h2>INDICATION and IMPORTANT SAFETY INFORMATION</h2>
</span></div>
			
      <div class="isi-inline-inner-wrap"><p class="subtitle subtitle-blue"><span class="nobr">JYNARQUE</span> is indicated to slow kidney function decline in adults at risk of rapidly progressing autosomal dominant polycystic kidney disease (ADPKD).</p><div class="fake-box"><p class="box-title mobile-only subtitle-blue"><strong>WARNING: RISK OF SERIOUS LIVER INJURY</strong></p><p class="center box-title desktop-only tablet-only subtitle-blue"><strong>WARNING: RISK OF SERIOUS LIVER INJURY</strong></p><ul><li><span class="nobr"><strong>JYNARQUE<sup>速</sup> (tolvaptan)</strong></span><strong> can cause serious and potentially fatal liver injury. Acute liver failure requiring liver transplantation has been reported</strong></li><li><strong>Measure transaminases (ALT, AST) and bilirubin before initiating treatment, at 2 weeks and 4 weeks after initiation, then monthly for the first 18 months and every 3&nbsp;months thereafter. Prompt action in response to laboratory abnormalities, signs, or symptoms indicative of&nbsp;hepatic injury can mitigate, but not eliminate, the risk of&nbsp;serious hepatotoxicity</strong></li><li><strong>Because of the risks of serious liver injury, </strong><span class="nobr"><strong>JYNARQUE</strong></span><strong> is available only through a Risk Evaluation and Mitigation Strategy program called the Tolvaptan for ADPKD Shared System REMS</strong></li></ul></div><p class="subtitle"><strong>CONTRAINDICATIONS:</strong></p><ul><li>History, signs or symptoms of significant liver impairment or injury. This contraindication does not apply to uncomplicated polycystic liver disease</li><li>Taking strong CYP3A inhibitors</li><li>With uncorrected abnormal blood sodium concentrations</li><li>Unable to sense or respond to thirst</li><li>Hypovolemia</li><li>Hypersensitivity (e.g., anaphylaxis, rash) to JYNARQUE or any component of the product</li><li>Uncorrected urinary outflow obstruction</li><li>Anuria</li></ul><p><strong>Serious Liver Injury:</strong> JYNARQUE can cause serious and potentially fatal liver injury. Acute liver failure requiring liver transplantation has been reported in the post-marketing ADPKD&nbsp;experience. Discontinuation in response to laboratory abnormalities or signs or symptoms of liver injury (such as fatigue, anorexia, nausea, right upper abdominal discomfort, vomiting, fever, rash, pruritus, icterus, dark urine or jaundice) can reduce the risk of severe hepatotoxicity. To reduce the risk of significant or irreversible liver injury, assess ALT, AST and bilirubin prior to initiating JYNARQUE, at 2 weeks and 4 weeks after initiation, then monthly for 18 months and every 3 months thereafter.</p><p><strong>Hypernatremia, Dehydration and Hypovolemia:</strong> JYNARQUE therapy increases free water clearance which can lead to dehydration, hypovolemia and hypernatremia. Instruct patients to drink water when thirsty, and throughout the day and night if awake. Monitor for weight loss, tachycardia and hypotension because they may signal dehydration. Ensure abnormalities in sodium concentrations are corrected before initiating therapy. If serum sodium increases above normal or the patient becomes hypovolemic or dehydrated and fluid intake cannot be increased, suspend JYNARQUE until serum sodium, hydration status and volume status parameters are within the normal range.</p><p><strong>Inhibitors of CYP3A:</strong> Concomitant use of JYNARQUE with drugs that are moderate or strong CYP3A inhibitors (e.g., ketoconazole, itraconazole, lopinavir/ritonavir, indinavir/ritonavir, ritonavir, and conivaptan) increases tolvaptan exposure. Use with strong CYP3A inhibitors is contraindicated; dose reduction of JYNARQUE is recommended for patients taking moderate CYP3A inhibitors. Patients should avoid grapefruit juice beverages while taking JYNARQUE.</p><p><strong>Adverse Reactions:</strong> Most common observed adverse reactions with JYNARQUE (incidence &gt;10% and at least twice that for placebo) were thirst, polyuria, nocturia, pollakiuria and polydipsia.</p><p><strong>Other Drug Interactions:</strong></p><ul><li><strong>Strong CYP3A Inducers:</strong> Co-administration with strong CYP3A inducers reduces exposure to JYNARQUE. Avoid concomitant use of JYNARQUE with strong CYP3A inducers</li><li><span class="nobr"><strong>V<sub>2</sub>-Receptor Agonist:</strong></span> Tolvaptan interferes with the <span class="nobr">V<sub>2</sub>-agonist</span> activity of desmopressin (dDAVP). Avoid concomitant use of JYNARQUE with a <span class="nobr">V<sub>2</sub>-agonist</span></li></ul><p><strong>Pregnancy and Lactation:</strong> Based on animal data, JYNARQUE may cause fetal harm. In general, JYNARQUE should be discontinued during pregnancy. Advise women not to breastfeed during treatment with JYNARQUE.</p><p class="reporting">To report SUSPECTED ADVERSE REACTIONS, contact Otsuka America Pharmaceutical, Inc. at <span class="nobr">1-800-438-9927</span> or FDA at <span class="nobr">1-800-FDA-1088</span> (<a class="cyan ext-link" href="https://www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program">www.fda.gov/medwatch</a>).</p><p class="pb-2">Please see <a class="cyan external-link-popup-disabled" href="https://www.otsuka-us.com/media/static/JYNARQUE-PI.pdf" target="_blank">FULL PRESCRIBING INFORMATION</a>, including <strong>BOXED WARNING</strong>.</p>
</div>
		</div>

	</section>

  </div>

      </div>
      </main>

</div>
    
<div id="interstitial-wrapper" class="interstitial-hidden">
  <div id="overlay-mask"></div>
  <div id="interstitial">
    <div class="interstitial-content-wrap-outer">
    <div class="interstitial-content-wrap-inner">
      <div class="interstitial primary-interstitial">
          <div class="region region-interstitial">
    <div id="block-interstitial" class="custom-block--interstitial block-content-interstitial block-content-basic-block">
  
    
      


                    <div class="body "><p class="interstitial-opener">You are now leaving</p>

<p class="interstitial-domain">JYNARQUEHCP.COM</p>

<p class="interstitial-instruction"><strong>Click "I Agree" to proceed.</strong></p>
</div>
            
  </div>

  </div>

        <a href="#" id="accept-exit" class="button external-link-popup-disabled">I Agree</a>
      </div>
            <div class="interstitial otsuka-interstitial">
          <div class="region region-interstitialotsuka">
    <div id="block-otsukapropertyinterstitial" class="custom-block--otsukapropertyinterstitial block-content-otsuka-property-interstitial block-content-basic-block">
  
    
      


                    <div class="body "><p class="interstitial-opener">You are now leaving</p>

<p class="interstitial-domain">JYNARQUEHCP.COM</p>

<p class="interstitial-copy">The website you are linking to is neither owned nor controlled by Otsuka America Pharmaceutical, Inc. (Otsuka).</p>

<p class="interstitial-copy">Otsuka is not responsible for the content or services on the site.</p>

<p class="interstitial-copy">The reprint you are linking to may include information that is not contained in the product labeling. Please see the <a href="https://www.otsuka-us.com/media/static/JYNARQUE-PI.pdf" target="_blank">FULL PRESCRIBING INFORMATION</a>, including <strong>BOXED WARNING</strong>, for complete product information.</p>

<p class="interstitial-copy">Click "Ok" to proceed or "Cancel" to return.</p>
</div>
            
  </div>

  </div>

        <a href="#" id="acceptotsuka" class="button external-link-popup-disabled">OK</a>
        <a href="#" id="cancelotsuka" class="button-transparent cancel-button">CANCEL</a>
      </div>
                  <div class="interstitial iassist-interstitial">
            <div class="region region-interstitialassist">
    <div id="block-iassistpartyinterstitialoverlay" class="custom-block--iassistpartyinterstitialoverlay block-content-iassist-party-interstitial-overlay block-content-basic-block">
  
    
      


                    <div class="body "><p class="interstitial-opener">Please ask your specialty pharmacy about the JYNARQUE Copay Support Program.</p>
</div>
            
  </div>

  </div>

      </div>
                  <div class="interstitial thirdparty-interstitial">
            <div class="region region-interstitial3p">
    <div id="block-3rdpartyinterstitial" class="custom-block---rdpartyinterstitial block-content-3rd-party-interstitial block-content-basic-block">
  
    
      


                    <div class="body "><p class="interstitial-opener">You are now leaving</p>

<p class="interstitial-domain">JYNARQUEHCP.COM</p>

<p class="interstitial-copy">Please be aware that Otsuka is not responsible for the content on the external website you are about to enter.</p>
</div>
            
  </div>

  </div>

          <a href="#" id="accept3p" class="button external-link-popup-disabled">OK</a>
          <a href="#" id="cancel3p" class="button-transparent cancel-button">CANCEL</a>
      </div>
          </div>
    </div>
  <button id="interstitial-close">Cancel</button>
  </div>
</div>

  </div>

    







<section id="drawer-isi" class="isi-tray jsIsiContainer isi-drawer-expanded resizing">

	<!--<div id="isi-drawer-wrapper" class="isi-drawer-collapsed">-->

    <div class="isi-header">
        <div class="isi-header-wrap">
            <div class="drawer-title"><h2>INDICATION and IMPORTANT SAFETY INFORMATION</h2>
</div>
            <button class="isi-btn jsIsiMinimize" data-oapigtmcategory="Button Clicks" data-oapigtmaction="ISI" data-oapigtmlabel="SEE MORE">
              <span class="jsSwapText jsSwapTextExpand hide">SEE MORE</span>
              <span class="jsSwapText jsSwapTextCollapse">MINIMIZE</span>
              <span class="isi-btn-icon"></span>
            </button>
        </div>
    </div>
	
	<div class="isi isi-block isi-drawer-content isi-content-wrap">
		<div class="jcf-scrollable jcf-container mCustomScrollbar">
      <div class="isi-drawer-content-heading"><h2>INDICATION and IMPORTANT SAFETY INFORMATION</h2>
</div>
      <p class="subtitle subtitle-blue"><span class="nobr">JYNARQUE</span> is indicated to slow kidney function decline in adults at risk of rapidly progressing autosomal dominant polycystic kidney disease (ADPKD).</p><div class="fake-box"><p class="box-title mobile-only subtitle-blue"><strong>WARNING: RISK OF SERIOUS LIVER INJURY</strong></p><p class="center box-title desktop-only tablet-only subtitle-blue"><strong>WARNING: RISK OF SERIOUS LIVER INJURY</strong></p><ul><li class="jsIsiVisible-mob"><span class="nobr"><strong>JYNARQUE<sup>速</sup> (tolvaptan)</strong></span><strong> can cause serious and potentially fatal liver injury. Acute liver failure requiring liver transplantation has been reported</strong></li><li class="jsIsiVisible-dt"><strong>Measure transaminases (ALT, AST) and bilirubin before initiating treatment, at 2 weeks and 4 weeks after initiation, then monthly for the first 18 months and every 3 months thereafter. Prompt action in response to laboratory abnormalities, signs, or symptoms indicative of&nbsp;hepatic injury can mitigate, but not eliminate, the risk of serious hepatotoxicity</strong></li><li><strong>Because of the risks of serious liver injury, </strong><span class="nobr"><strong>JYNARQUE</strong></span><strong> is available only through a Risk Evaluation and Mitigation Strategy program called the Tolvaptan for ADPKD Shared System REMS</strong></li></ul></div><p class="subtitle"><strong>CONTRAINDICATIONS:</strong></p><ul><li>History, signs or symptoms of significant liver impairment or injury. This contraindication does not apply to uncomplicated polycystic liver disease</li><li>Taking strong CYP3A inhibitors</li><li>With uncorrected abnormal blood sodium concentrations</li><li>Unable to sense or respond to thirst</li><li>Hypovolemia</li><li>Hypersensitivity (e.g., anaphylaxis, rash) to JYNARQUE or any component of the product</li><li>Uncorrected urinary outflow obstruction</li><li>Anuria</li></ul><p><strong>Serious Liver Injury:</strong> JYNARQUE can cause serious and potentially fatal liver injury. Acute liver failure requiring liver transplantation has been reported in the post-marketing ADPKD&nbsp;experience. Discontinuation in response to laboratory abnormalities or signs or symptoms of liver injury (such as fatigue, anorexia, nausea, right upper abdominal discomfort, vomiting, fever, rash, pruritus, icterus, dark urine or jaundice) can reduce the risk of severe hepatotoxicity. To reduce the risk of significant or irreversible liver injury, assess ALT, AST and bilirubin prior to initiating JYNARQUE, at 2 weeks and 4 weeks after initiation, then monthly for 18 months and every 3 months thereafter.</p><p><strong>Hypernatremia, Dehydration and Hypovolemia:</strong> JYNARQUE therapy increases free water clearance which can lead to dehydration, hypovolemia and hypernatremia. Instruct patients to drink water when thirsty, and throughout the day and night if awake. Monitor for weight loss, tachycardia and hypotension because they may signal dehydration. Ensure abnormalities in sodium concentrations are corrected before initiating therapy. If serum sodium increases above normal or the patient becomes hypovolemic or dehydrated and fluid intake cannot be increased, suspend JYNARQUE until serum sodium, hydration status and volume status parameters are within the normal range.</p><p><strong>Inhibitors of CYP3A:</strong> Concomitant use of JYNARQUE with drugs that are moderate or strong CYP3A inhibitors (e.g., ketoconazole, itraconazole, lopinavir/ritonavir, indinavir/ritonavir, ritonavir, and conivaptan) increases tolvaptan exposure. Use with strong CYP3A inhibitors is contraindicated; dose reduction of JYNARQUE is recommended for patients taking moderate CYP3A inhibitors. Patients should avoid grapefruit juice beverages while taking JYNARQUE.</p><p><strong>Adverse Reactions:</strong> Most common observed adverse reactions with JYNARQUE (incidence &gt;10% and at least twice that for placebo) were thirst, polyuria, nocturia, pollakiuria and polydipsia.</p><p><strong>Other Drug Interactions:</strong></p><ul><li><strong>Strong CYP3A Inducers:</strong> Co-administration with strong CYP3A inducers reduces exposure to JYNARQUE. Avoid concomitant use of JYNARQUE with strong CYP3A inducers</li><li><strong>V<sub>2</sub>-Receptor Agonist:</strong> Tolvaptan interferes with the&nbsp;V<sub>2</sub>-agonist activity of desmopressin (dDAVP). Avoid concomitant use of JYNARQUE with a&nbsp;V<sub>2</sub>-agonist</li></ul><p><strong>Pregnancy and Lactation:</strong> Based on animal data, JYNARQUE may cause fetal harm. In general, JYNARQUE should be discontinued during pregnancy. Advise women not to breastfeed during treatment with JYNARQUE.</p><p class="reporting">To report SUSPECTED ADVERSE REACTIONS, contact Otsuka America Pharmaceutical, Inc. at <span class="nobr">1-800-438-9927</span> or FDA at <span class="nobr">1-800-FDA-1088</span> (<a class="cyan ext-link" href="https://www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program" data-analytics-name="www.fda.gov/medwatch">www.fda.gov/medwatch</a>).</p><p>Please see <a class="cyan external-link-popup-disabled" href="https://www.otsuka-us.com/media/static/JYNARQUE-PI.pdf" target="_blank" data-analytics-name="FULL PRESCRIBING INFORMATION">FULL PRESCRIBING INFORMATION</a>, including <strong>BOXED WARNING</strong>.</p>

    </div>
	</div>

	<!--</div>--><!--/#isi-drawer-wrapper-->

</section>
<style>
	
	.isi-tray {
		left: 0%;
		width: 100%;
	}
	.isi-drawer-expanded {
		height: 220px;
	}
	.isi-drawer-collapsed {
		height: 200px;
	}

    .isi-tray.isi-drawer-expanded .isi-content-wrap,
    .isi-tray.isi-drawer-expanded .isi-content-wrap>div {
        height: calc(50vh - 380px);
    }
    @media all and (min-width: 768px) {
        .isi-tray.isi-drawer-expanded .isi-content-wrap,
        .isi-tray.isi-drawer-expanded .isi-content-wrap>div {
            height: calc(50vh - 220px);
        }
    }
}

</style>


    
    
<footer>
    <div class="footer-container">

                <div class="footer-row">
            <div class="footer-nav">
                  <div class="region region-footer-nav">
    <nav role="navigation" aria-labelledby="block-jynarque-hcp-footer-menu" id="block-jynarque-hcp-footer" class="custom-block--jynarque-hcp-footer" data-test='privacy-menu'>
            
  <div class="visually-hidden" id="block-jynarque-hcp-footer-menu">Footer menu</div>
  

        
              <ul block="block-jynarque-hcp-footer" region="footer_nav" data-test="footer-menu">
              <li>

                <a href="https://www.otsuka-us.com/privacy-policy" target="_blank" class="ext-link">Privacy Policy</a>
              </li>
          <li>

                <a href="https://www.otsuka-us.com/terms-and-conditions" target="_blank" class="ext-link">Terms of Use</a>
              </li>
        </ul>
  


  </nav>

  </div>

            </div>
        </div>
        
        <div id="mobile-tablet-branding" class="footer-row">
            <div class="footer-otsuka">
                  <div class="region region-footer-branding-otsuka">
    <div id="block-otsukabrandingfooter" class="custom-block--otsukabrandingfooter block-content-otsuka-branding-footer block-content-basic-block">
  
    
      


                    <div class="body "><p><a class="ext-link" href="https://www.otsuka-us.com/" data-analytics-name="Otsuka America Pharmaceutical, Inc., Logo" target="_blank" aria-label=" (opens in a new window)"><img src="../sites/g/files/qhldwo11641/files/inline-images/otsuka_logo2.png" data-entity-uuid="c466d6d1-5a41-4fbc-b91a-a1c601e50800" data-entity-type="file" alt="Otsuka America Pharmaceutical, Inc., Logo" width="492" height="98" loading="lazy"></a></p></div>
            
  </div>

  </div>

            </div>
        </div>

        <div id="desktop-bottom-footer-row">
            <div class="desktop-credits-wrapper">
                <div class="footer-row">
                        <div class="footer-otsuka desktop" data-test='navbar-branding'>
                              <div class="region region-footer-branding-otsuka">
    <div id="block-otsukabrandingfooter" class="custom-block--otsukabrandingfooter block-content-otsuka-branding-footer block-content-basic-block">
  
    
      


                    <div class="body "><p><a class="ext-link" href="https://www.otsuka-us.com/" data-analytics-name="Otsuka America Pharmaceutical, Inc., Logo" target="_blank" aria-label=" (opens in a new window)"><img src="../sites/g/files/qhldwo11641/files/inline-images/otsuka_logo2.png" data-entity-uuid="c466d6d1-5a41-4fbc-b91a-a1c601e50800" data-entity-type="file" alt="Otsuka America Pharmaceutical, Inc., Logo" width="492" height="98" loading="lazy"></a></p></div>
            
  </div>

  </div>

                        </div>
                        <div class="footer-credits">
                            
                        </div>
                </div>

                <div class="footer-row">
                    <div class="footer-mobile-left">
                        <div class="footer-copyright" data-test='copyright'>
                              <div class="region region-footer-copyright">
    <div id="block-otsukacopyright" class="custom-block--otsukacopyright">
  
    
      息2025 Otsuka America Pharmaceutical, Inc.
  </div>
<div id="block-sitecopyright" class="custom-block--sitecopyright block-content-site-copyright block-content-basic-block">
  
    
      


                    <div class="body "><p>All rights reserved.</p></div>
            
  </div>

  </div>

                        </div>
                        <div class="footer-review-date">
                              <div class="region region-footer-review-date">
    <div id="block-prcdate" class="custom-block--prcdate">
  
    
      <span class="prc-info-date" data-test='prc-date'>April 2025</span>
  </div>


  </div>

                        </div>
                        <div class="footer-prc-code">
                              <div class="region region-footer-prc-code">
    <div id="block-prccode" class="custom-block--prccode">
  
    
      <span class="prc-info-code" data-test='prc-code'>10US25EBP0095</span>
  </div>


  </div>

                        </div>
                    </div>
                </div>
            </div>
            
        </div>    
    </div>
</footer>    <script src="../sites/g/files/qhldwo11641/files/js/optimized/js_5lyEgtuYzFbknt789sXbvgY6WOEBhn68zCRaGR5wIJc.pydd31qeaVwnZ7zmVFZER7RdslYTSa4L05Z96Bj0rpAfe04.js?v=10.5.0"></script>
<script src="../sites/g/files/qhldwo11641/files/js/optimized/js_G8podNJjOsxKvo_RVe4-f79_ME43boCp5OhhwF87kOc.CmHewv09bU-2iMTQUA9fYmgUfGdx8v6eCV0c0HTKVv0fe04.js?v=10.5.0"></script>
<script src="../sites/g/files/qhldwo11641/files/js/optimized/js_RpLV1j1SEgkAOBNxIxvzKXRlefOlhPa03lpGt46bJEg.ipSHo_VRPfgKJstENA8BEd0ZaAk6UUuLrs-5LtKGyFwfe04.js?v=10.5.0"></script>
<script src="../sites/g/files/qhldwo11641/files/js/optimized/js_mFzUkjUxStqgHC8aG7xRbdL6fE1PCi6EiNgqsEIWhqc.akPIL5F6ygowEntokyWY4_Tg4pNQtEi97UIJcojA29M1cee.js?t5xpr9"></script>
<script src="../sites/g/files/qhldwo11641/files/js/optimized/js_rpx3pOPcK6hnLQR-Fef4P6UMSJh-ihuV9hqkMm_cMdk.vTghGNUkYqEi22uPg-gGp3H22SpaHZoLjn_xZk1ITwka0fc.js?v=1.x"></script>
<script src="../sites/g/files/qhldwo11641/files/js/optimized/js_8rI11XUPmo8bNSGc51T6ByOCso4FQ5AktRkneJJL7Nc.AyNUrL50y9uFK4-l6wxy1y5SzvrnEuWYvX8Ai1_oSMca0fc.js?v=1.x"></script>
<script src="../sites/g/files/qhldwo11641/files/js/optimized/js_aGpgzbkylt8snB-EXgmHtxvxOZAT-qDmrVPgkGVG71I.ojHXLPZwCg6JiUQKM9w4QZF_TUslDSaGc0h3XjA--Zwa0fc.js?v=1.x"></script>
<script src="../sites/g/files/qhldwo11641/files/js/optimized/js_t6WcaYLAw6hjWSihMsQXThEsPYFBj0NBE18VKsjijws.EX9XtAmarEWHxG8VqWLQlmsKC8tS6zrY_UhL31ekHLca0fc.js?v=1.x"></script>

    </div>
  </body>


</html>
